Academic Identity

Vidwan-ID : 451197

Edit Profile


  • Dr Ravikiran Yedidi

  • Professor of Practice
  • Andhra University
Publications 2006 - 2022

Publications

  • 24
    Journal Articles
  • 1
    Conference
    Proceedings
  • 2
    Review
  • 16
    Projects

Co-author Network

Expertise

Biochemistry and Molecular Biology

Drug discovery, Genetic Engineering, Structural Biology, Virology, Cancer Biology

Personal Information

Dr Ravikiran Yedidi

Male
Room no. 30, 31, 32 Zoology building, Andhra University
Visakhapatnam, Andhra Pradesh, India - 530003

Experience

  • Professor of Practice

    Department of Biotechnology

    Andhra University

  • Visiting Professor

    Department of Zoology

    Andhra University

  • Scientist F

    Instem

    Ministry of Science & Technology, Department of Biotechnology, DBT

  • Research Associate

    Biochemistry

    University of Toronto

  • Visiting Fellow

    HIV and AIDS Malignancy Branch

    National Institutes of Health

  • Research Scholar

    Biochemistry, Wayne State University

    University of Michigan

Qualification

  • Ph.D.

    Wayne State Medical School, USA.

  • M.S.

    Wayne State University, USA.

  • M.Sc.

    Andhra University, India.

  • B.Sc.

    Andhra University, India.

Honours and Awards

2009

Cancer Research Training Award

National Institutes of Health, USA.

2004

Research Assistantship

Wayne State Medical School, USA.

2001

Graduate Teaching Assistantship

Wayne State University, USA.

2009

Cancer Research Training Award

National Institutes of Health, USA.

2004

Research Assistantship

Wayne State Medical School, USA.

2001

Graduate Teaching Assistantship

Wayne State University, USA.

Read Less

Doctoral Theses Guided

2011

Crystallographic, Molecular Dynamics, and Enzymatic Studies of Multi-Drug Resistant HIV-1 Protease and Implications for Structure-Based Drug Design.

Zhigang Liu, Wayne State Medical School

2011

Crystallographic, Molecular Dynamics, and Enzymatic Studies of Multi-Drug Resistant HIV-1 Protease and Implications for Structure-Based Drug Design.

Zhigang Liu, Wayne State Medical School

Read Less

Membership In Professional Bodies

2013

American Society for Microbiology

Postdoctoral Fellow

2012

International AIDS Society

Postdoctoral Fellow

2008

American Society for Biochemistry and Molecular Biology

Doctoral Student

Read More
2013

American Society for Microbiology

Postdoctoral Fellow

2012

International AIDS Society

Postdoctoral Fellow

2008

American Society for Biochemistry and Molecular Biology

Doctoral Student

2007

Advanced Photon Source, Argonne National Laboratories

Beam user

2006

American Crystallographic Association

Doctoral Student

Read Less

Research Projects

CCBT-BRCA1 Initiative

Funding Agency : Department of Biotechnology, India.

Development of Antiviral Therapy of HIV-1 Infection

Funding Agency : National Cancer Institute, NIH, USA.

Development of antiviral therapy for HIV-1 infection

Funding Agency : National Cancer Institute, NIH, USA.

Read More

CCBT-BRCA1 Initiative

Funding Agency : Department of Biotechnology, India.

Development of Antiviral Therapy of HIV-1 Infection

Funding Agency : National Cancer Institute, NIH, USA.

Development of antiviral therapy for HIV-1 infection

Funding Agency : National Cancer Institute, NIH, USA.

Development of Antiviral Therapy of HIV-1 Infection

Funding Agency : National Cancer Institute, NIH, USA.

Development of Antiviral Therapy of HIV-1 Infection

Funding Agency : National Cancer Institute, NIH, USA.

Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors

Funding Agency : Nactional Cancer Institute, NIH, USA.

Structure-based drug design for mutidrug-resistant HIV-1 protease variants

Funding Agency : National Institutes of Health, USA.

Design, synthesis and biological evaluation of novel small molecules for the treatment of infections caused by Helicobacter pylori.

Funding Agency : Private: TyiDE-Toronto

Design and biological evaluation of a novel yogurt-based edible vaccine for COVID-19 and other viral infections including cancers.

Funding Agency : Private: TCABS-E

Evaluating the effects of human vaginal microbiome on harvesting the endometrial stem cells.

Funding Agency : Private: TyiDE-Toronto

Protein liquid-liquid phase separation formulations for RNA therapeutics in cancer and infectious diseases.

Funding Agency : Private: TyiDE-Toronto

Adverse effects of nucleotide analogs on the cytochrome P450-3A4 and their physiological consequences.

Funding Agency : Private: TCABS-E

Design and construction of genetic circuits for plastic biodegradation using the synthetic biology platform.

Funding Agency : Private: TyiDE-Toronto

Molecular dynamics simulations of proteins and protein-drug complexes to evaluate the in silico binding affinities in drug discovery.

Funding Agency : Private: TCABS-E

Evaluation of structural deviations in the spike protein of coronavirus and their consequences on vaccine efficacy.

Funding Agency : Private: TyiDE-Toronto

Novel RNA therapeutics using chemical biology to target the ceRNA that are involved in silencing the apoptotic pathways.

Funding Agency : Private: TyiDE-Toronto

Read Less

Patents




Read More









Read Less

Publications (27)

Powered by